WHCI
ABBV icon

W.H. Cornerstone Investments’s AbbVie ABBV Stock Holding History

W.H. Cornerstone Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$882K Buy
3,505
+1,788
+104% +$385K 0.5% 44
2026
Q1 		$373K Buy
+1,717
New +$381K 0.23% 83

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

W.H. Cornerstone Investments's ABBV Position: Q2 2026 in Review

W.H. Cornerstone Investments increased its AbbVie (ABBV) stake by 104% in Q2 2026, buying an estimated $385K and bringing the position to 3,505 shares worth $882K. The position accounts for 0.5% of the portfolio, ranked #44.

W.H. Cornerstone Investments first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 4,222 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • W.H. Cornerstone Investments held 3,505 shares of AbbVie worth $882K as of Q2 2026.
  • W.H. Cornerstone Investments bought 1,788 AbbVie shares in Q2 2026, an estimated $385K.
  • AbbVie made up 0.5% of W.H. Cornerstone Investments's portfolio in Q2 2026, its #44 holding.
  • W.H. Cornerstone Investments first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • 4,222 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on W.H. Cornerstone Investments's 13F filing for Q2 2026, filed 7 Aug 2026.